Alcon (SWX:ALC) shares are in focus after the company agreed a non exclusive collaboration with RxSight to co develop ...
Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...
Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...
Over the last several years, the RxSight team has been developing proprietary hybrid IOL materials for next-generation light adjustable technology that can support a full suite of adjustable lenses ...
Medical Device Network on MSN
Alcon spends up to $200M to co-develop customisable cataract lenses with RxSight
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...
SEOUL, SOUTH KOREA, May 29, 2026 /EINPresswire.com/ — Dr. Chung Eui Sang, Chief Director of SNU Eye Clinic in Korea, recently served as moderator at the “Clareon ...
Gdansk, May 6 (Reuters) - Swiss-American eye care company Alcon (ALCC.S), opens new tab reported a 10% rise in its quarterly revenue, citing recent product launches as the main drivers. Sign up here.
TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2 TruPlus demonstrates higher distance image quality across ...
EXCLUSIVE: The Garfield Movie producer Alcon Media Group wants Parrot Analytics to inform its IP strategy following its acquisition of 108 Village Roadshow Entertainment Group feature films. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results